Home/Filings/4/0001298079-25-000003
4//SEC Filing

Brazzell Romulus K 4

Accession 0001298079-25-000003

CIK 0001479419other

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 8:00 PM ET

Size

5.5 KB

Accession

0001298079-25-000003

Insider Transaction Report

Form 4
Period: 2025-10-22
Transactions
  • Sale

    Common Stock

    2025-10-22$0.83/sh46,748$38,80135,952 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F2]Includes 35,952 unvested RSUs.

Issuer

KALA BIO, Inc.

CIK 0001479419

Entity typeother

Related Parties

1
  • filerCIK 0001298079

Filing Metadata

Form type
4
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 8:00 PM ET
Size
5.5 KB